Your session is about to expire
← Back to Search
Imaging Techniques for Aortic Aneurysm
N/A
Recruiting
Led By Houssam Farres, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with non-aneurysmal aortas who require aortic contrast imaging or echocardiography for preoperative planning or other reason
Patients with non-aneurysmal aortas who require aortic contrast imaging or echocardiography for preoperative planning or other reason.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline ecg-gated imaging measurements.
Awards & highlights
Study Summary
This trial is testing whether two new imaging methods can accurately measure the stiffness of the aorta.
Who is the study for?
This trial is for adults over 18 who can consent and need aortic imaging or echocardiography, including those with abdominal aortic aneurysms (AAA) that are larger than normal. It's not for those without imaging needs, with IV contrast allergies or severe kidney issues, terminally ill patients, or those unable to undergo MRI.Check my eligibility
What is being tested?
The study tests the feasibility of using two new imaging methods—ECHO and ECG-gated MRA—to measure the biomechanical properties of healthy and aneurysmal aortas in various patients.See study design
What are the potential side effects?
While this study focuses on imaging techniques rather than drug interventions, potential side effects may include discomfort from lying still during scans and risks associated with exposure to contrast agents if applicable.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I need special heart imaging but don't have an aortic aneurysm.
Select...
I need imaging for my heart or aorta for surgery planning or another reason, and I don't have an aortic aneurysm.
Select...
My aorta is at least 1.5 times its normal size.
Select...
My aorta is at least 1.5 times its normal size.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline in echo imaging measurements
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline in echo imaging measurements
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
ECHO Imaging
Secondary outcome measures
ECG-gated MRA Imaging
Trial Design
3Treatment groups
Active Control
Group I: Surgery-EVARActive Control2 Interventions
EVAR with ECHO and ECG-gated MRA imaging.
Group II: Surgery-OpenActive Control2 Interventions
Open Surgery with ECHO and ECG-gated MRA imaging.
Group III: SurveillanceActive Control2 Interventions
No Surgery with ECHO and ECG-gated MRA imaging.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,213 Previous Clinical Trials
3,766,981 Total Patients Enrolled
Houssam Farres, MDPrincipal Investigator - Mayo Clinic
Mayo Clinic Hospital Jacksonville
3 Previous Clinical Trials
62 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I need special heart imaging but don't have an aortic aneurysm.I need imaging for my heart or aorta for surgery planning or another reason, and I don't have an aortic aneurysm.I am over 18 and can give my consent.My aorta is at least 1.5 times its normal size.You have a very serious illness, and doctors think you may have less than 6 months to live.I cannot have IV contrast due to an allergy or severe kidney issues.You cannot undergo a magnetic resonance imaging (MRI) scan.My aorta is at least 1.5 times its normal size.I don't need dye imaging or heart ultrasound for my treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Surgery-EVAR
- Group 2: Surgery-Open
- Group 3: Surveillance
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies in this clinical experiment for participants?
"Affirmative. Clinicaltrials.gov data indicates that this clinical trial, which was first announced on August 1st 2015, is actively recruiting patients at the moment. 30 participants must be enrolled from a single site for participation in the study to be successful."
Answered by AI
What is the maximum capacity for enrolment in this trial?
"Correct. According to clinicaltrials.gov, this medical trial is currently recruiting patients with a commencement date of August 1st 2015 and an update published on October 6th 2022. The research requires 30 participants at one site in particular."
Answered by AI
Who else is applying?
What state do they live in?
Texas
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Share this study with friends
Copy Link
Messenger